Active Pharmaceutical Ingredients and High Potency API Industry Data Book - Active Pharmaceutical Ingredients and High Potency Active Pharmaceutical Ingredients Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030

Published Date: Feb, 2023
Report ID: sector-report-00137
Format: Electronic (PDF)
Number of Pages: 0

Chapter 1 Methodology and Scope

1.1 Market Segmentation
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective 1
1.11.2 Objective 2
1.12 List Of Abbreviations

Chapter 2 Market Definitions

2.1 Definitions

Chapter 3 Executive Summary

3.1 Market Summary

Chapter 4 Global API and High Potency API Variables, Trends, & Scope

4.1 API and High Potency API Market Lineage Outlook
4.1.1 Parent Market Outlook
4.2 Penetration And Growth Prospect Mapping
4.3 Regulatory Framework
4.4 Market Driver Analysis
4.4.1 Increasing prevalence of target diseases such as hospital-acquired infections, genetic, cardiovascular, and neurological diseases
4.4.2 Increasing preference for targeted therapy approach in cancer treatment
4.4.3 Increasing preference for outsourcing APIs
4.4.4 Increasing application of HPAPIs
4.5 Market Restraint Analysis
4.5.1 Large investments and very stringent safety and handling specifications associated with the production of HPAPIs
4.5.2 Stringent safety and handling regulations regarding APIs
4.6 Value Chain Analysis
4.6.1 Value Chain Analysis/Route To Market
4.7 Consumer Behavior Analysis
4.8 Major Deals and Strategic Alliances Analysis
4.8.1 New product launch
4.8.2 Mergers and acquisitions
4.8.3 Expansion
4.8.4 Partnerships
4.8.5 Marketing & promotions
4.8.6 Market entry strategies
4.9 API Market Analysis Tools
4.9.1 Industry Analysis - Porter’s
4.9.2 SWOT Analysis, By Pest
4.10 HPAPI Market Analysis Tools
4.10.1 Industry Analysis - Porter’s
4.10.2 SWOT Analysis, By Pest

Chapter 5 API and High Potency API Market - Segment Analysis, by Type of Synthesis, 2018- 2030 (USD Million)

5.1 API and High Potency API Market: Type of Synthesis Movement Analysis
5.1.1 API and High Potency API Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2 Biotech
5.2.1 Biotech Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.3 Synthetic
5.3.1 Synthetic Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 API and High Potency API Market - Segment Analysis, by Type of Manufacturer, 2018 - 2030 (USD Million)

6.1 API and High Potency API Market: Type of Manufacturer Movement Analysis
6.2 Captive APIs
6.2.1 Captive APIs Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3 Merchant APIs
6.3.1 Merchant APIs Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7 API and High Potency API Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)

7.1 API and High Potency API Market: Type Movement Analysis
7.2 Innovative APIs
7.2.1 Innovative APIs Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3 Generic APIs
7.3.1 Generic APIs Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8 API and High Potency API Market - Segment Analysis, by Application, 2018 - 2030 (USD Million)

8.1 API and High Potency API Market: Application Movement Analysis
8.2 Cardiovascular Diseases
8.2.1 Cardiovascular Diseases Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3 Oncology
8.3.1 Oncology Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4 CNS and Neurology
8.4.1 CNS and Neurology Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5 Orthopedic
8.5.1 Orthopedic Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6 Endocrinology
8.6.1 Endocrinology Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.7 Pulmonology
8.7.1 Pulmonology Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.8 Gastroenterology
8.8.1 Gastroenterology Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.9 Nephrology
8.9.1 Nephrology Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.10 Ophthalmology
8.10.1 Ophthalmology Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.11 Others
8.11.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 9 API and High Potency API Market - Segment Analysis, by Region, 2018 - 2030 (USD Million)

9.1 API and High Potency API Market: Regional Movement Analysis
9.2 North America
9.2.1 North America, SWOT Analysis
9.2.2 North America API and High Potency API Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.2.3 U.S.
9.2.3.1 U.S. API and High Potency API Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.2.4 Canada
9.2.4.1 Canada API and High Potency API Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3 Europe
9.3.1 Europe, SWOT Analysis
9.3.2 Europe API and High Potency API Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.3 U.K.
9.3.3..1 U.K. API and High Potency API Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.4 Germany
9.3.4.1 Germany API and High Potency API Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.5 Spain
9.3.5.1 Spain API and High Potency API Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.6 France
9.3.6.1 France API and High Potency API Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.9 Italy
9.3.9.1 Italy API and High Potency API Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.8 Russia
9.3.8.1 Russia API and High Potency API Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.9 Russia
9.3.9.1 Russia API and High Potency API Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.10 Norway
9.3.10.1 Norway API and High Potency API Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.11 Sweden
9.3.11.1 Sweden API and High Potency API Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.12 Denmark
9.3.12.1 Denmark API and High Potency API Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4 Asia Pacific
9.4.1 Asia Pacific, SWOT Analysis
9.4.2 Asia Pacific API and High Potency API Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4.3 Japan
9.4.3.1 Japan API and High Potency API Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4.4 China
9.4.4.1 China API and High Potency API Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4.5 India
9.4.5.1 India API and High Potency API Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4.6 South Korea
9.4.6.1 South Korea API and High Potency API Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4.9 Singapore
9.4.9.1 Singapore API and High Potency API Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4.8 Australia
9.4.8.1 Australia API and High Potency API Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4.9 Thailand
9.4.9.1 Thailand API and High Potency API Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5 Latin America
9.5.1 Latin America, SWOT Analysis
9.5.2 Latin America Market API and High Potency API Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.3 Brazil
9.5.3.1 Brazil API and High Potency API Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.4 Mexico
9.5.4.1 Mexico API and High Potency API Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.5 Argentina
9.5.5.1 Argentina API and High Potency API Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6 Middle East and Africa
9.6.1 Middle East & Africa, SWOT Analysis
9.6.2 Middle-East And Africa API and High Potency API Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6.3 South Africa
9.6.3.1 South Africa Market API and High Potency API Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6.4 United Arab Emirates
9.6.4.1 United Arab API and High Potency API Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6.5 Saudi Arabia
9.6.5.1 Saudi Arabia API and High Potency API Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6.6 Kuwait
9.6.6.1 Kuwait API and High Potency API Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 10 Competitive Analysis

10.1 Recent Developments & Impact Analysis, By Key Market Participants
10.1.1 Ansoff Matrix
10.1.2 Company/Competition Categorization (Key Innovators, Market Leaders, Expansion)
10.1.3 Innovators
10.2 Vendor Landscape
10.2.1 List Of Key Distributors And Channel Partners
10.2.2 Global API Market: Key Company Market Share Analysis, 2021
10.2.3 Global HPAPI Market: Key Company Market Share Analysis, 2021
10.2.4 Global API and High Potency API Market: Key Company Market Share Analysis, 2021
10.3 Public Companies
10.3.1 Company Market Position Analysis
10.3.2 Competitive Dashboard Analysis
10.3.3 Strategic Framework
10.4 Private Companies
10.4.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
10.4.2 Regional Network Map
10.5 Company Profiles
10.5.1 Merck & Co., Inc.
10.5.1.1 Company Overview
10.5.1.2 Alere, Inc.
10.5.1.3 Financial Performance
10.5.1.4 Product Benchmarking
10.5.1.5 Strategic Initiatives
10.5.2 AbbVie, Inc.
10.5.2.1 Company Overview
10.5.2.2 Financial Performance
10.5.2.3 Product Benchmarking
10.5.2.4 Strategic Initiatives
10.5.3 Bristol-Myers Squibb Company.
10.5.3.1 Company Overview
10.5.3.2 Financial Performance
10.5.3.3 Product Benchmarking
10.5.3.4 Strategic Initiatives
10.5.4 Boehringer Ingelheim International GmbH.
10.5.4.1 Company Overview
10.5.4.2 Financial Performance
10.5.4.3 Product Benchmarking
10.5.4.4 Strategic Initiatives
10.5.5 Cipla, Inc.
10.5.5.1 Company Overview
10.5.5.2 Financial Performance
10.5.5.3 Product Benchmarking
10.5.5.4 Strategic Initiatives
10.5.6 Teva Pharmaceutical Industries Ltd.
10.5.6.1 Company Overview
10.5.6.2 Financial Performance
10.5.6.3 Product Benchmarking
10.5.6.4 Strategic Initiatives
10.5.7 Albemarle Corporation
10.5.7.1 Company Overview
10.5.7.2 Financial Performance
10.5.7.3 Product Benchmarking
10.5.7.4 Strategic Initiatives
10.5.8 Viatris Inc.
10.5.10.1 Company Overview
10.5.10.2 Financial Performance
10.5.10.3 Product Benchmarking
10.5.10.4 Strategic Initiatives
10.5.9 Aurobindo Pharma
10.5.9.1 Company Overview
10.5.9.2 Financial Performance
10.5.9.3 Product Benchmarking
10.5.9.4 Strategic Initiatives
10.5.10 Sun Pharmaceutical Industries Ltd.
10.5.10.1 Company Overview
10.5.10.2 Financial Performance
10.5.10.3 Product Benchmarking
10.5.10.4 Strategic Initiatives
10.5.11 Dr. Reddy’s Laboratories Ltd.
10.5.11.1 Company Overview
10.5.11.2 Financial Performance
10.5.1.3 Product Benchmarking
10.5.1.4 Strategic Initiatives
10.5.12 BASF SE
10.5.12.1 Company Overview
10.5.12.2 Financial Performance
10.5.12.3 Product Benchmarking
10.5.12.4 Strategic Initiatives
10.5.13 CordenPharma
10.5.13.1 Company Overview
10.5.13.2 Financial Performance
10.5.13.3 Product Benchmarking
10.5.13.4 Strategic Initiatives
10.5.14 Dr. Reddy’s Laboratories Ltd.
10.5.14.1 Company Overview
10.5.14.2 Financial Performance
10.5.14.3 Product Benchmarking
10.5.14.4 Strategic Initiatives
10.5.15 Pfizer, Inc..
10.5.15.1 Company Overview
10.5.15.2 Financial Performance
10.5.15.3 Product Benchmarking
10.5.15.4 Strategic Initiatives
10.5.16 Sanofi
10.5.16.1 Company Overview
10.5.16.2 Financial Performance
10.5.16.3 Product Benchmarking
10.5.16.4 Strategic Initiatives
10.5.17 F. Hoffmann La Roche Ltd.
10.5.17.1 Company Overview
10.5.17.2 Financial Performance
10.5.17.3 Product Benchmarking
10.5.17.4 Strategic Initiatives

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.